Work

MPN-541 Targeted Therapy of Uncontrolled Erythrocytosis in Polycythemia Vera With the Hepcidin Mimetic, Rusfertide: Blinded Randomized Withdrawal Results of the Phase 2 Revive Study

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01253-3

Authors: Naveen Pemmaraju, Marina Kremyanskaya, Andrew Kuykendall, Ellen Ritchie, Jason Gotlib, Aaron Gerds, Jeanne Palmer, Kristen Pettit, Uttam Nath, Abdulraheem Yacoub, Arturo Molina, Nishit Modi, Frank Valone, Sarita Khanna, Suneel Gupta, Srdan Verstovsek, Yelena Ginzburg, Ronald Hoffman

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4386277469

Cites:

Cited by: 1

Related to: 10